BR112023021310A2 - Mitigação de criptosporidiose com o uso de composições geradoras de peróxido de hidrogênio - Google Patents
Mitigação de criptosporidiose com o uso de composições geradoras de peróxido de hidrogênioInfo
- Publication number
- BR112023021310A2 BR112023021310A2 BR112023021310A BR112023021310A BR112023021310A2 BR 112023021310 A2 BR112023021310 A2 BR 112023021310A2 BR 112023021310 A BR112023021310 A BR 112023021310A BR 112023021310 A BR112023021310 A BR 112023021310A BR 112023021310 A2 BR112023021310 A2 BR 112023021310A2
- Authority
- BR
- Brazil
- Prior art keywords
- cryptosporidiosis
- animals
- hydrogen peroxide
- compositions
- generating compositions
- Prior art date
Links
- 208000008953 Cryptosporidiosis Diseases 0.000 title abstract 6
- 206010011502 Cryptosporidiosis infection Diseases 0.000 title abstract 6
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 title abstract 6
- 239000000203 mixture Substances 0.000 title abstract 6
- 230000000116 mitigating effect Effects 0.000 title abstract 2
- 241001465754 Metazoa Species 0.000 abstract 9
- 241000223935 Cryptosporidium Species 0.000 abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 2
- 210000003250 oocyst Anatomy 0.000 abstract 2
- 241000223936 Cryptosporidium parvum Species 0.000 abstract 1
- 244000309466 calf Species 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/14—Pretreatment of feeding-stuffs with enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/20—Animal feeding-stuffs from material of animal origin
- A23K10/26—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin
- A23K10/28—Animal feeding-stuffs from material of animal origin from waste material, e.g. feathers, bones or skin from waste dairy products
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/105—Aliphatic or alicyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/163—Sugars; Polysaccharides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/189—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/22—Compounds of alkali metals
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K40/00—Shaping or working-up of animal feeding-stuffs
- A23K40/30—Shaping or working-up of animal feeding-stuffs by encapsulating; by coating
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/20—Feeding-stuffs specially adapted for particular animals for horses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/44—Oxidoreductases (1)
- A61K38/443—Oxidoreductases (1) acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biotechnology (AREA)
- Physiology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
mitigação de criptosporidiose com o uso de composições geradoras de peróxido de hidrogênio. trata-se de composições para prevenir ou diminuir criptosporidiose em animais reveladas no presente documento. as composições incluem fontes de peróxido de hidrogênio e são alimentadas a animais. os animais podem ser bezerros neonatais e a criptosporidiose pode ser causada por cryptosporidium parvum. são também revelados métodos de prevenção ou diminuição de criptosporidiose em animais através da alimentação das composições geradoras de peróxido de hidrogênio aos animais. alguns métodos revelados reduzem o número de oocistos de cryptosporidium expelidos por um animal infectado ou reduzem a infectividade de oocistos de cryptosporidium expelidos por um animal infectado. alguns métodos incluem alimentar as composições geradoras de peróxido de hidrogênio a animais por fim afligidos com criptosporidiose, e os animais ganho peso apesar da infecção.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202163175015P | 2021-04-14 | 2021-04-14 | |
PCT/US2022/024569 WO2022221380A1 (en) | 2021-04-14 | 2022-04-13 | Mitigation of cryptosporidiosis using hydrogen peroxide-generating compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112023021310A2 true BR112023021310A2 (pt) | 2023-12-12 |
Family
ID=83603128
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112023021310A BR112023021310A2 (pt) | 2021-04-14 | 2022-04-13 | Mitigação de criptosporidiose com o uso de composições geradoras de peróxido de hidrogênio |
Country Status (6)
Country | Link |
---|---|
US (1) | US20220331356A1 (pt) |
CN (1) | CN117412678A (pt) |
BR (1) | BR112023021310A2 (pt) |
MX (1) | MX2023012094A (pt) |
TW (1) | TW202304479A (pt) |
WO (1) | WO2022221380A1 (pt) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2024008734A1 (en) * | 2022-07-08 | 2024-01-11 | Unibio Tech Science A/S | Ruminant feed |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0619786D0 (en) * | 2006-10-06 | 2006-11-15 | Inst Of Technology Sligo | An antimicrobial and immunostimulatory system |
CN101821385A (zh) * | 2007-05-10 | 2010-09-01 | 丹尼斯科美国公司 | 稳定的酶促过酸产生系统 |
CN102203231B (zh) * | 2008-11-03 | 2013-09-11 | 丹尼斯科美国公司 | 用于共配制的酶和底物的输送系统 |
US20110229598A1 (en) * | 2010-03-18 | 2011-09-22 | Land O'lakes Purina Feed Llc | Enhanced lactoperoxidase system for treatment of milk products |
GB201816558D0 (en) * | 2018-10-10 | 2018-11-28 | Slainte Beoga Teoranta | Antibiotic-free antimicrobial feed additives and antimicrobial compositions |
-
2022
- 2022-04-13 WO PCT/US2022/024569 patent/WO2022221380A1/en active Application Filing
- 2022-04-13 MX MX2023012094A patent/MX2023012094A/es unknown
- 2022-04-13 US US17/719,674 patent/US20220331356A1/en active Pending
- 2022-04-13 CN CN202280039226.5A patent/CN117412678A/zh active Pending
- 2022-04-13 TW TW111114073A patent/TW202304479A/zh unknown
- 2022-04-13 BR BR112023021310A patent/BR112023021310A2/pt unknown
Also Published As
Publication number | Publication date |
---|---|
WO2022221380A1 (en) | 2022-10-20 |
CN117412678A (zh) | 2024-01-16 |
TW202304479A (zh) | 2023-02-01 |
US20220331356A1 (en) | 2022-10-20 |
MX2023012094A (es) | 2023-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
McKenzie et al. | Selenium: an essential element for immune function | |
BRPI0704238A (pt) | preventivo da doença de coccidiose e clostrìdica e/ou terapia para a doença de coccidiose e clostridica | |
CL2016000240A1 (es) | Composición inmunogénica de reovirus de peces (prv) que comprende ácido nucleico del prv; polipéptido; virus atenuado o inactivado del prv, uso de la composición inmunogénica que sirve para tratar afecciones de infeción por prv en un animal. | |
BR112023021310A2 (pt) | Mitigação de criptosporidiose com o uso de composições geradoras de peróxido de hidrogênio | |
AR093185A1 (es) | Virus prrs (sindrome reproductivo y respiratorio porcino) que induce al interferon tipo i en celulas susceptibles | |
AR122899A1 (es) | Combinación de vacunas | |
BR112012020839A2 (pt) | vacinas para uso na profilaxe e tratamento de doença de vírus da influenza | |
CL2018000925A1 (es) | Aditivos de piensos para animales acuáticos | |
UY29915A1 (es) | Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina | |
RU2014134365A (ru) | Вакцины против clostridium difficile, включающие рекомбинантные токсины | |
BR112019012158A2 (pt) | vacinação eficaz contra cepas europeias de vírus da síndrome reprodutiva e respiratória suína (prrs) antes do desmame | |
BR112021013140A2 (pt) | Construções de terapia gênica para tratar doença de wilson | |
AR080313A1 (es) | Composiciones de virus de moquillo canino (cdv) recombinante y sus usos | |
CL2017002846A1 (es) | Métodos de tratamiento de trastornos linfoproliferativos asociados al virus de epstein-barr por terapia con células t. | |
Lu et al. | Overexpression of histone deacetylase 6 enhances resistance to porcine reproductive and respiratory syndrome virus in pigs | |
CO2022014256A2 (es) | Vacuna contra la infección por el virus de la peste porcina africana | |
CL2020001344A1 (es) | Tratamiento antisentido del síndrome de angelman. | |
BR112015017903A2 (pt) | vacina de subunidade de mycobacterium avium subsp. paratuberculosis única ou de múltiplos estágios | |
BR112016012435A8 (pt) | vacina, e, usos de uma proteína orf2 recombinantemente expressada do circovírus porcino tipo 2 | |
MX2020005235A (es) | Celula humana transformada y uso de la misma. | |
CL2023002187A1 (es) | Virus para vacuna contra el síndrome respiratorio y reproductivo porcino | |
AR048671A1 (es) | Procedimiento de vacunacion contra la infeccion testicular por bvdv | |
AR085800A1 (es) | Vacuna de rinitis equina | |
BR112021025286A2 (pt) | Vacina contra o hiv com base em células t alogênicas para induzir a imunidade celular e humoral | |
Reggiori et al. | Sexual precocity, reproductive efficiency and productive performance of Nelore and crossbred young cows |